| Literature DB >> 28337437 |
Abstract
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) represent a potential unlimited cell supply for cardiac tissue engineering and possibly regenerative medicine applications. However, hPSC-CMs produced by current protocols are not representative of native adult human cardiomyocytes as they display immature gene expression profile, structure and function. In order to improve hPSC-CM maturity and function, various approaches have been developed, including genetic manipulations to induce gene expression, delivery of biochemical factors, such as triiodothyronine and alpha-adrenergic agonist phenylephrine, induction of cell alignment in 3D tissues, mechanical stress as a mimic of cardiac load and electrical stimulation/pacing or a combination of these. In this mini review, we discuss biomimetic strategies for the maturation for hPSC-CMs with a particular focus on electromechanical conditioning methods.Entities:
Keywords: biomaterials; cardiac regeneration; cardiomyocytes; cell therapy; electrical stimulation; mechanical stimulation; stem cell
Year: 2017 PMID: 28337437 PMCID: PMC5343210 DOI: 10.3389/fcell.2017.00019
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) vs. adult ventricular cardiomyocytes.
| Structure | Shape | Round | Rod | Gerdes et al., | |
| Cell surface area | 10212–14418 μm2 | 500–1294 μm2 | Li et al., | ||
| Gene Expression | MYH7 < MYH6 TNNI3 < TNNI1 | MYH7 > MYH6 TNNI3 > TNNI1 | Xu et al., | ||
| Nuclei | Mononuclear | 25% binucleation | Olivetti et al., | ||
| Sarcomere | ~1.65 μm | ~2.2 μm | Van Der Velden et al., | ||
| T-tubules | Absent | Present | Brette and Orchard, | ||
| Energy and force | Mitochondria | Near nuclei, small fraction | Throughout cell; 20–40% of cell volume | Schaper et al., | |
| Energy | Glycolysis | ß-oxidation of fatty acid | Lopaschuk and Jaswal, | ||
| Contractile force | 0.22 ± 0.70 to 11.8 ± 4.5 mN/mm2 | 51 ±8 mN/mm2 | Van Der Velden et al., | ||
| Proliferation | Early hPSC-CM: Yes Late hPSC-CM: No | Considered non-proliferative | Bergmann et al., | ||
| Calcium transients | Inefficient | Efficient | Itzhaki et al., | ||
| Excitation-contraction coupling | Slow | Fast | Yang et al., | ||
| AP(action potential) properties | Upstroke velocity | 15–50 V/s | 180–400 V/s | Dangman et al., | |
| Resting membrane potential | −20 to −60 mV | −90 mV | Drouin et al., | ||
| Conduction velocity | 2.1–20 cm/s | 41–84 cm/s | Nanthakumar et al., | ||
| Capacitance | 5–30 pF | 150 pF | Drouin et al., | ||
| Automaticity | Spontaneous beating | Quiescent | Chen et al., | ||
| mRNA level | Ca | Similar to adult cardiomyocyte | – | Satin et al., | |
| Ca | 20 fold lower than adult cardiomyocyte | – | Satin et al., | ||
| RyR2 | ~1000 fold lower than adult cardiomyocyte | – | Satin et al., | ||
| Ion channel density (pA/pF) | I | −20 to −330 | ~−50 | Valdivia et al., | |
| I | −2.2 to −11 | −2.3 to ~−10 | Magyar et al., | ||
| I | 2.5–13.7 | 2.3–9.2 | Beuckelmann et al., | ||
| I | 0.3–0.7 | 0.18 | Virag et al., | ||
| I | 0.4–0.8 | 0.6 | Jost et al., | ||
| I | −0.6 to −3.4 | ~−12 | Schram et al., | ||
| I | 3.6–7.9 (Ca2+ inward mode) | 2.5–3 | Weber et al., | ||
Figure 1Schematic diagram illustrating the strategies to promote and the assessment of the maturation of human pluripotent stem cell (hPSC)-derived cardiomyocytes (hPSC-CM). These approaches may be used individually or in any combination to promote hPSC-CM maturation. The assessment of the maturation should be physiologically relevant, including readout from morphology (cell alignment, cell shape/size, sarcomeres and T-tubules), gene expression (sarcomeric, ion channels and their regulators), and function (calcium handling, ECC, electrophysiology, contraction and transplantation).